|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for GOT1 |
Basic gene info. | Gene symbol | GOT1 |
Gene name | glutamic-oxaloacetic transaminase 1, soluble | |
Synonyms | ASTQTL1|GIG18|cAspAT|cCAT | |
Cytomap | UCSC genome browser: 10q24.1-q25.1 | |
Genomic location | chr10 :101156626-101190530 | |
Type of gene | protein-coding | |
RefGenes | NM_002079.2, | |
Ensembl id | ENSG00000120053 | |
Description | aspartate aminotransferase 1aspartate aminotransferase, cytoplasmicaspartate transaminase 1cysteine aminotransferase, cytoplasmiccysteine transaminase, cytoplasmicglutamate oxaloacetate transaminase 1growth-inhibiting protein 18transaminase A | |
Modification date | 20141207 | |
dbXrefs | MIM : 138180 | |
HGNC : HGNC | ||
Ensembl : ENSG00000120053 | ||
HPRD : 00687 | ||
Vega : OTTHUMG00000018882 | ||
Protein | UniProt: P17174 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_GOT1 | |
BioGPS: 2805 | ||
Gene Expression Atlas: ENSG00000120053 | ||
The Human Protein Atlas: ENSG00000120053 | ||
Pathway | NCI Pathway Interaction Database: GOT1 | |
KEGG: GOT1 | ||
REACTOME: GOT1 | ||
ConsensusPathDB | ||
Pathway Commons: GOT1 | ||
Metabolism | MetaCyc: GOT1 | |
HUMANCyc: GOT1 | ||
Regulation | Ensembl's Regulation: ENSG00000120053 | |
miRBase: chr10 :101,156,626-101,190,530 | ||
TargetScan: NM_002079 | ||
cisRED: ENSG00000120053 | ||
Context | iHOP: GOT1 | |
cancer metabolism search in PubMed: GOT1 | ||
UCL Cancer Institute: GOT1 | ||
Assigned class in ccmGDB | A - This gene has a literature evidence and it belongs to cancer gene. | |
References showing role of GOT1 in cancer cell metabolism | 1. Jiang X, Chang H, Zhou Y (2015) Expression, purification and preliminary crystallographic studies of human glutamate oxaloacetate transaminase 1 (GOT1). Protein Expr Purif 113: 102-106. doi: 10.1016/j.pep.2015.05.010. go to article 2. Chakrabarti G (2015) Mutant KRAS associated malic enzyme 1 expression is a predictive marker for radiation therapy response in non-small cell lung cancer. Radiat Oncol 10: 145. doi: 10.1186/s13014-015-0457-x. pmid: 4502640. go to article |
Top |
Phenotypic Information for GOT1(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: GOT1 |
Familial Cancer Database: GOT1 |
* This gene is included in those cancer gene databases. |
Oncogene 1 | Significant driver gene in CRC 6, |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 6 http://www.nature.com/nature/journal/v505/n7484/full/nature12912.html, 7Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM KEGG_CYSTEINE_AND_METHIONINE_METABOLISM KEGG_ARGININE_AND_PROLINE_METABOLISM KEGG_TYROSINE_METABOLISM KEGG_PHENYLALANINE_METABOLISM REACTOME_SULFUR_AMINO_ACID_METABOLISM REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES REACTOME_METABOLISM_OF_POLYAMINES REACTOME_METABOLISM_OF_CARBOHYDRATES REACTOME_GLUCOSE_METABOLISM |
Others | |
OMIM | 138180; gene. 614419; phenotype. |
Orphanet | |
Disease | KEGG Disease: GOT1 |
MedGen: GOT1 (Human Medical Genetics with Condition) | |
ClinVar: GOT1 | |
Phenotype | MGI: GOT1 (International Mouse Phenotyping Consortium) |
PhenomicDB: GOT1 |
Mutations for GOT1 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
There's no structural variation information in COSMIC data for this gene. |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows GOT1 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
AI114691 | GOT1 | 30 | 319 | 10 | 101180445 | 101190377 | FABP1 | 304 | 643 | 2 | 88424050 | 88427579 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
There's no copy number variation information in COSMIC data for this gene. |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=32) | (# total SNVs=8) |
(# total SNVs=1) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr10:101180424-101180424 | p.R86H | 2 |
chr10:101163500-101163501 | p.S258F | 2 |
chr10:101163552-101163552 | p.I241S | 2 |
chr10:101163327-101163327 | p.S286S | 2 |
chr10:101163586-101163586 | p.A230T | 2 |
chr10:101157386-101157386 | p.R387Q | 2 |
chr10:101163356-101163356 | p.E277* | 2 |
chr10:101163595-101163595 | p.Q227* | 2 |
chr10:101180382-101180382 | p.R100Q | 1 |
chr10:101162397-101162397 | p.P348S | 1 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample |   |   |   | 8 |   |   | 3 |   |   |   |   | 3 | 2 |   |   | 1 | 6 | 4 |   | 6 |
# mutation |   |   |   | 9 |   |   | 3 |   |   |   |   | 4 | 2 |   |   | 1 | 6 | 4 |   | 10 |
nonsynonymous SNV |   |   |   | 5 |   |   | 1 |   |   |   |   | 3 | 1 |   |   | 1 | 4 | 3 |   | 9 |
synonymous SNV |   |   |   | 4 |   |   | 2 |   |   |   |   | 1 | 1 |   |   |   | 2 | 1 |   | 1 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr10:101180424 | p.R86H | 2 |
chr10:101163586 | p.G262W | 2 |
chr10:101163490 | p.A230T | 2 |
chr10:101162431 | p.A344A | 1 |
chr10:101163546 | p.Q227E | 1 |
chr10:101163312 | p.S336S | 1 |
chr10:101163585 | p.K214T | 1 |
chr10:101180428 | p.I291I | 1 |
chr10:101163320 | p.Q208H | 1 |
chr10:101180532 | p.E289K | 1 |
Other DBs for Point Mutations |
Copy Number for GOT1 in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for GOT1 |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
ATP5B,ATP5G3,ATP5O,BOLA3,CCNB1,COX5A,COX7B, CWF19L1,DDT,GOT1,MDH1,MRPS22,NDUFA6,PGAM1, PTTG1,RFC2,SHMT2,SLC25A5,SUCLG1,UFD1L,USMG5 | ASB4,BEST3,PERM1,CTXN3,EEF1A2,FEM1A,FHL3, GOT1,IP6K3,JPH1,MYADML2,MYOM2,MYOZ2,PEBP4, PFKM,PGPEP1L,SLC25A4,SRPK3,SYNPO2L,TRIM54,WDR62 | ||||
ATP5B,ATP5G3,ATP5O,CHCHD10,COX7C,COX8A,ECHS1, FH,GHITM,GOT1,MRPS5,NDUFB8,NDUFS3,NDUFV1, PGAM1,SDHB,TMX2,UBAC1,UQCRC1,UQCRH,USMG5 | APEH,ATP5A1,ATP5B,DARS2,DLAT,FAR2,FASTKD1, FH,GOT1,GSS,MIPEP,MRRF,PDHA1,PDSS2, RTN4IP1,SLC25A10,SLC35A4,SUPV3L1,TBRG4,TTLL12,TUFM |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for GOT1 |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Chemistry | ChEMBL | CHEMBL2189139; -. |
Organism-specific databases | PharmGKB | PA28817; -. |
Organism-specific databases | CTD | 2805; -. |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00114 | glutamic-oxaloacetic transaminase 1, soluble | nutraceutical | Pyridoxal Phosphate | ||
DB00128 | glutamic-oxaloacetic transaminase 1, soluble | approved; nutraceutical | L-Aspartic Acid | ||
DB00142 | glutamic-oxaloacetic transaminase 1, soluble | approved; nutraceutical | L-Glutamic Acid | ||
DB00151 | glutamic-oxaloacetic transaminase 1, soluble | approved; nutraceutical | L-Cysteine | ||
DB04299 | glutamic-oxaloacetic transaminase 1, soluble | experimental | Maleic Acid | ||
DB00121 | glutamic-oxaloacetic transaminase 1, soluble | approved; nutraceutical | Biotin | ||
DB00130 | glutamic-oxaloacetic transaminase 1, soluble | approved; nutraceutical; investigational | L-Glutamine |
Top |
Cross referenced IDs for GOT1 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |